Anthony D. Ho
European Molecular Biology Organization(DE)Kyoto University(JP)Heidelberg University(DE)FibroGen (United States)(US)Heidelberg University(US)Stanford University(US)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.(1998)2,755 cited
- → Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood(2005)1,251 cited
- → Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)(2008)1,130 cited
- → Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process(2008)1,109 cited
- → Human haematopoietic stem cell lineage commitment is a continuous process(2017)912 cited
- → Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group